|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -99.33% |
| 08-06 | Morphic Medical Announces Board Appointments, Effective August 6, 2026 | CI |
| 08-03 | Morphic Medical Inc. Provides Update On Reset System Clinical And Commercial Progress | CI |
| Market Cap | 440K 387K 365K 333K 623K 42.28M 628K 4.38M 1.7M 21.52M 1.65M 1.62M 70.03M | P/E 2019 |
-1.12x | P/E 2020 | -0.03x |
|---|---|---|---|---|---|
| Enterprise Value | 3.28M 2.88M 2.72M 2.48M 4.64M 315M 4.68M 32.63M 12.65M 160M 12.31M 12.05M 521M | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
-
| Yield 2019 * |
-
| Yield 2020 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mike Gutteridge
CEO | Chief Executive Officer | - | 2025-08-04 |
Jane Wright
DFI | Director of Finance/CFO | 57 | 2025-07-31 |
| Chief Tech/Sci/R&D Officer | - | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ginger Glaser
BRD | Director/Board Member | - | 2020-10-19 |
Alex Escalona
BRD | Director/Board Member | - | - |
John R. Barr
BRD | Director/Board Member | 69 | 2023-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/28/21 | Free | Chairman | 1,384,483 | 0.4875% | ||
| 1/28/21 | Free | Chief Executive Officer | 11,075,869 | 3.8998% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -17.33M -15.25M -14.37M -13.11M -24.52M -1.66B -24.71M -172M -66.83M -847M -65.08M -63.67M -2.76B | -11.14M -9.8M -9.23M -8.42M -15.75M -1.07B -15.88M -111M -42.94M -544M -41.81M -40.9M -1.77B |
| Net Debt | 2.89M 2.54M 2.39M 2.18M 4.08M 277M 4.12M 28.73M 11.13M 141M 10.84M 10.6M 459M | 2.84M 2.5M 2.35M 2.15M 4.02M 273M 4.05M 28.25M 10.95M 139M 10.66M 10.43M 451M |
Employees
-
Sector
-
- Stock Market
- Stocks
- GIDYL Stock
Select your edition
All financial news and data tailored to specific country editions
















